08:58 AM EDT, 03/12/2026 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday the US Food and Drug Administration has approved its Tecnis PureSee intraocular lens for use in cataract surgery.

The company said the lens is designed to improve vision at different distances while maintaining clear visual quality.

The drugmaker said the lens can help treat both cataracts and presbyopia, an age-related condition that reduces the ability to see objects up close. It aims to improve distance and intermediate vision while reducing patients' reliance on glasses.

Johnson & Johnson ( JNJ ) said the Tecnis PureSee lens will become available to patients in the US later this year.